Does TYSABRI Cause Progressive multifocal leukoencephalopathy? 66 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 66 reports of Progressive multifocal leukoencephalopathy have been filed in association with TYSABRI. This represents 0.8% of all adverse event reports for TYSABRI.
66
Reports of Progressive multifocal leukoencephalopathy with TYSABRI
0.8%
of all TYSABRI reports
13
Deaths
57
Hospitalizations
How Dangerous Is Progressive multifocal leukoencephalopathy From TYSABRI?
Of the 66 reports, 13 (19.7%) resulted in death, 57 (86.4%) required hospitalization, and 8 (12.1%) were considered life-threatening.
Is Progressive multifocal leukoencephalopathy Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TYSABRI. However, 66 reports have been filed with the FAERS database.
What Other Side Effects Does TYSABRI Cause?
Multiple sclerosis relapse (811)
Fatigue (759)
Malaise (523)
Gait disturbance (445)
Multiple sclerosis (443)
Memory impairment (422)
Headache (368)
Drug ineffective (329)
Asthenia (328)
Fall (324)
What Other Drugs Cause Progressive multifocal leukoencephalopathy?
NATALIZUMAB (1,668)
RITUXIMAB (1,647)
CYCLOPHOSPHAMIDE (782)
PREDNISONE (606)
PREDNISOLONE (439)
TACROLIMUS (438)
METHOTREXATE (428)
DOXORUBICIN (421)
MYCOPHENOLATE MOFETIL (414)
VINCRISTINE (376)
Which TYSABRI Alternatives Have Lower Progressive multifocal leukoencephalopathy Risk?
TYSABRI vs TYVASO
TYSABRI vs UBIDECARENONE
TYSABRI vs UBLITUXIMAB
TYSABRI vs UBLITUXIMAB-XIIY
TYSABRI vs UBROGEPANT